CaMKII-mediated increased lusitropic responses to β-adrenoreceptor stimulation in ANP-receptor deficient mice

Cardiovascular Research

Volumn 73, Issue 4, 2007, Pages 678-688

  Yurukova, Sevdalina ^a   Kilić, Ana ^a   Völker, Katharina ^a   Leineweber, Kirsten ^b   Dybkova, Nataliya ^c   Maier, Lars S ^c   Brodde, Otto Erich ^b   Kuhn, Michaela ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Atrial natriuretic peptide; Calcium cycling; CaMKII; Cyclic GMP; Guanylyl cyclase A; Heart failure; Phospholamban

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; BETA ADRENERGIC RECEPTOR; CALCIUM; CATECHOLAMINE DERIVATIVE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANYLATE CYCLASE ACTIVATOR; INDO 1; PHOSPHOLAMBAN; PROTEIN KINASE (CALCIUM,CALMODULIN) II; REGULATOR PROTEIN; RYANODINE RECEPTOR; SERINE; THREONINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME INHIBITION; GENE DISRUPTION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HYPERTENSION; ISOLATED HEART; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM; STIMULUS RESPONSE; VASODILATATION; WESTERN BLOTTING; WILD TYPE;

ADRENERGIC BETA-AGONISTS; ANIMALS; BLOTTING, WESTERN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CALCIUM-BINDING PROTEINS; CARDIOMEGALY; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOBUTAMINE; ENZYME ACTIVATION; HYPERTENSION; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; MYOCARDIAL CONTRACTION; PERFUSION; PHOSPHORYLATION; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; STIMULATION, CHEMICAL;

EID: 33846874155     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.10.003     Document Type: Article

References (27)

1. Kuhn M. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 93 (2003) 700-709
2. Holtwick R., van Eickels M., Skryabin B.V., Baba H.A., Bubikat A., Begrow F., et al. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 111 (2003) 1399-1407
3. Kishimoto I., Rossi K., and Garbers D.L. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci U S A 98 (2001) 2703-2706
4. Tamura N., Ogawa Y., Chusho H., Nakamura K., Nakao K., Suda M., et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A 97 (2000) 4239-4244
5. Kuhn M., Voss M., Mitko D., Stypmann J., Schmid C., Kawaguchi N., et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc Res 64 (2004) 308-314
6. Singh G., Kuc R.E., Maguire J.J., Fidock M., and Davenport A.P. Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure. Circ Res 99 (2006) 183-190
7. Lopez M.J., Wong S.K., Kishimoto I., Dubois S., Mach V., Friesen J., et al. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378 (1995) 65-68
8. Oliver P.M., Fox J.E., Kim R., Rockman H.A., Kim H.S., Reddick R.L., et al. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci U S A 94 (1997) 14730-14735
9. Skryabin B.V., Holtwick R., Fabritz L., Kruse M.N., Veltrup I., Stypmann J., et al. Hypervolemic hypertension in mice with systemic inactivation of the (floxed) guanylyl cyclase-A gene by alphaMHC-Cre-mediated recombination. Genesis 39 (2004) 288-298
10. Kuhn M., Holtwick R., Baba H.A., Perriard J.C., Schmitz W., and Ehler E. Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice. Heart 87 (2002) 368-374
11. Pogwizd S.M., Schlotthauer K., Li L., Yuan W., and Bers D.M. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 88 (2001) 1159-1167
12. +exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice. Circulation 112 (2005) 2307-2317
13. Xiao R.P., Zhu W., Zheng M., Chakir K., Bond R., Lakatta E.G., et al. Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 25 (2004) 358-365
14. Kohlhaas M., Zhang T., Seidler T., Zibrova D., Dybkova N., Steen A., et al. Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes. Circ Res 98 (2006) 235-244
15. Seyfarth T., Gerbershagen H.P., Giessler C., Leineweber K., Heinroth-Hoffmann I., Ponicke K., et al. The cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats. J Mol Cell Cardiol 32 (2000) 2315-2326
16. Hagemann D., and Xiao R.-P. Dual site phospholamban phosphorylation and its physiological relevance in the heart. Trends Cardiovasc Med 12 (2002) 51-56
17. 1-adrenergic receptor-mediated regulation of β-adrenergic signaling. J Biol Chem 272 (1997) 21253-21259
18. 2+/calmodulin kinase signaling pathway. Circ Res 95 (2004) 798-806
19. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
20. 2+ release. Circ Res 92 (2003) 904-911
21. Xiao B., Zhong G., Obayashi M., Yang D., Chen K., Walsh M.P., et al. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon β-adrenergic stimulation in normal and failing hearts. Biochem J 396 (2006) 7-16
22. 2+ current trigger. J Physiol 556 (2004) 463-480
23. 2+ homeostasis and cardiac contractility. Am J Physiol (2006) H599-H606
24. Hein S., Kostin S., and Heling A. The role of the cytoskeleton in heart failure. Cardiovasc Res 45 (2000) 273-278
25. 17 in cardiac physiological and pathological conditions. Cardiovasc Res 68 (2005) 366-375
26. 2+/Calmodulin Kinase. J Clin Invest 111 (2003) 617-625
27. c isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 92 (2003) 912-919